• Nationwide study finds stage, not biology, drives early-onset CRC outcomes

    Among 80,551 Dutch patients, those under 50 more often presented with stage III or IV disease and left-sided or rectal tumors, but after accounting for these factors, survival matched that of 50–69 year-olds. (EClinicalMedicine)